[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Citations 0
Correction
December 10, 2003

Recent Advances and Future Frontiers in Treating Age-Related Cataracts—Correction

JAMA. 2003;290(22):2943. doi:10.1001/jama.290.22.2943-a

Omitted Financial Disclosure: In the Contempo Updates article entitled "Recent Advances and Future Frontiers in Treating Age-Related Cataracts" published in the July 9, 2003, issue of THE JOURNAL (2003;290:248-251), a financial disclosure was not reported. The following should have been included: "Financial Disclosure: Dr Donnenfeld receives research support from Alcon, which manufactures moxifloxacin and ciprofloxacin for ophthalmic use. He also receives research support and is a consultant for Allergan, which manufactures gatifloxacin and ofloxacin for ophthalmic use."

×